Molecular Partners Ag Stock Price History

MOLN Stock  USD 4.80  0.12  2.44%   
If you're considering investing in Molecular Stock, it is important to understand the factors that can impact its price. As of today, the current price of Molecular Partners stands at 4.80, as last reported on the 17th of February 2025, with the highest price reaching 4.82 and the lowest price hitting 4.80 during the day. Molecular Partners has Sharpe Ratio of -0.0439, which conveys that the firm had a -0.0439 % return per unit of risk over the last 3 months. Molecular Partners exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Molecular Partners' Risk Adjusted Performance of (0.05), mean deviation of 2.71, and Standard Deviation of 3.76 to check out the risk estimate we provide.
  
As of the 17th of February 2025, Stock Based Compensation To Revenue is likely to grow to 0.70, while Total Stockholder Equity is likely to drop about 137.3 M. . At this time, Molecular Partners' Price To Sales Ratio is very stable compared to the past year. As of the 17th of February 2025, Price Sales Ratio is likely to grow to 20.88, while Price Earnings Ratio is likely to drop (1.72). Molecular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0439

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMOLN

Estimated Market Risk

 3.47
  actual daily
30
70% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Molecular Partners is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecular Partners by adding Molecular Partners to a well-diversified portfolio.
Price Book
1.1647
Enterprise Value Ebitda
1.2347
Price Sales
29.4807
Shares Float
6.5 M
Wall Street Target Price
10.5486

Molecular Partners Stock Price History Chart

There are several ways to analyze Molecular Stock price data. The simplest method is using a basic Molecular candlestick price chart, which shows Molecular Partners price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 27, 20245.83
Lowest PriceDecember 31, 20244.75

Molecular Partners February 17, 2025 Stock Price Synopsis

Various analyses of Molecular Partners' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Molecular Stock. It can be used to describe the percentage change in the price of Molecular Partners from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Molecular Stock.
Molecular Partners Price Rate Of Daily Change 0.98 
Molecular Partners Price Daily Balance Of Power(6.00)
Molecular Partners Price Action Indicator(0.07)

Molecular Partners February 17, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Molecular Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Molecular Partners intraday prices and daily technical indicators to check the level of noise trading in Molecular Stock and then apply it to test your longer-term investment strategies against Molecular.

Molecular Stock Price History Data

The price series of Molecular Partners for the period between Tue, Nov 19, 2024 and Mon, Feb 17, 2025 has a statistical range of 1.45 with a coefficient of variation of 5.8. The daily prices for the period are spread out with arithmetic mean of 5.35. The median price for the last 90 days is 5.33.
OpenHighLowCloseVolume
02/17/2025
 4.92  4.82  4.80  4.80 
02/17/2025
 4.92  4.82  4.80  4.80 
02/14/2025 4.82  4.82  4.80  4.80  2,623 
02/13/2025 4.92  4.92  4.92  4.92  1.00 
02/12/2025 4.92  4.92  4.92  4.92  214.00 
02/11/2025 4.96  5.05  4.87  4.92  2,100 
02/10/2025 5.10  5.10  5.10  5.10  2,555 
02/07/2025 4.97  4.97  4.97  4.97  21.00 
02/06/2025 5.12  5.12  4.86  4.97  3,629 
02/05/2025 4.94  4.94  4.89  4.89  1,564 
02/04/2025 5.04  5.04  5.04  5.04  991.00 
02/03/2025 5.05  5.15  5.05  5.05  1,531 
01/31/2025 5.20  5.35  5.14  5.16  6,528 
01/30/2025 5.24  5.24  5.23  5.23  5,482 
01/29/2025 5.23  5.23  5.22  5.22  2,153 
01/28/2025 5.31  5.31  5.31  5.31  254.00 
01/27/2025 5.41  5.41  5.25  5.31  8,093 
01/24/2025 5.33  5.33  5.33  5.33  416.00 
01/23/2025 5.33  5.33  5.33  5.33  7,858 
01/22/2025 5.33  5.33  5.33  5.33  1,700 
01/21/2025 5.25  5.30  5.25  5.30  4,232 
01/17/2025 5.45  5.56  5.40  5.56  5,000 
01/16/2025 5.44  5.81  5.44  5.81  3,846 
01/15/2025 5.49  5.91  5.49  5.78  13,044 
01/14/2025 5.49  5.50  5.36  5.36  6,640 
01/13/2025 5.50  5.50  5.14  5.40  10,814 
01/10/2025 5.10  5.46  4.98  4.98  7,552 
01/08/2025 5.23  5.50  5.23  5.49  8,602 
01/07/2025 5.26  5.46  5.26  5.46  10,172 
01/06/2025 5.09  5.13  5.00  5.06  4,500 
01/03/2025 5.08  5.12  4.87  4.87  4,921 
01/02/2025 4.99  5.20  4.85  4.87  7,032 
12/31/2024 4.84  4.98  4.75  4.75  7,300 
12/30/2024 5.13  5.13  4.76  4.99  9,341 
12/27/2024 5.30  5.30  5.28  5.30  2,626 
12/26/2024 5.31  5.31  5.31  5.31  1,428 
12/24/2024 5.31  5.31  5.31  5.31  2,450 
12/23/2024 5.44  5.44  5.44  5.44  2,138 
12/20/2024 5.19  5.19  5.06  5.08  14,993 
12/19/2024 5.21  5.25  5.17  5.22  2,600 
12/18/2024 5.46  5.46  5.30  5.30  15,985 
12/17/2024 5.33  5.33  5.25  5.25  2,281 
12/16/2024 5.44  5.44  5.26  5.35  30,088 
12/13/2024 5.41  5.45  5.41  5.43  2,604 
12/12/2024 5.59  5.65  5.45  5.55  20,366 
12/11/2024 5.54  5.58  5.41  5.51  8,518 
12/10/2024 5.73  5.95  5.50  5.63  106,697 
12/09/2024 5.79  5.79  5.61  5.61  9,143 
12/06/2024 5.75  5.81  5.69  5.72  40,092 
12/05/2024 5.99  5.99  5.56  5.81  67,467 
12/04/2024 5.88  5.88  5.78  5.83  4,475 
12/03/2024 5.50  5.71  5.49  5.51  2,352 
12/02/2024 5.80  5.95  5.34  5.40  168,758 
11/29/2024 5.87  5.87  5.82  5.82  852.00 
11/27/2024 5.83  5.83  5.79  5.83  1,793 
11/26/2024 5.78  5.78  5.57  5.65  1,909 
11/25/2024 5.54  5.80  5.40  5.62  5,902 
11/22/2024 5.29  5.29  5.29  5.29  785.00 
11/21/2024 5.48  5.48  5.16  5.42  11,685 
11/20/2024 5.42  5.46  5.19  5.20  29,940 
11/19/2024 5.51  6.15  5.29  5.46  18,160 

About Molecular Partners Stock history

Molecular Partners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Molecular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Molecular Partners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Molecular Partners stock prices may prove useful in developing a viable investing in Molecular Partners
Last ReportedProjected for Next Year
Common Stock Shares Outstanding37.7 M26 M
Net Income Applicable To Common Shares135.5 M142.3 M

Molecular Partners Quarterly Net Working Capital

139.1 Million

Molecular Partners Stock Technical Analysis

Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Molecular Partners technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Molecular Partners trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Molecular Partners Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Molecular Partners' price direction in advance. Along with the technical and fundamental analysis of Molecular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Molecular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Molecular Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molecular Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molecular Partners Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molecular Partners Ag Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Revenue Per Share
0.182
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.21)
Return On Equity
(0.37)
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.